Results 191 to 200 of about 3,583 (231)
Some of the next articles are maybe not open access.

The response of the human Fallopian tube to ergonovine and methyl-ergonovine in vivo

American Journal of Obstetrics and Gynecology, 1976
Ergonovine maleate (EM) is a powerful stimulant of human tubal motility. It has been therefore thought that EM could interfere with normal ovum transport and serve as a contraceptive. The tube activating effects of EM and methyl EM were evaluated in 14 women and results confirmed that both are powerful stimulants of the human Fallopian tube.
E M, Coutinho, H, Maia, L, Nascimento
openaire   +2 more sources

Ergonovine Provocation in Post Partum Myocardial Infarction

Angiology, 1984
Post-partum myocardial infarction is rare and the pathophysiology obscure. This report describes a 30-year-old lactating female in whom an infero-lateral wall myocardial infarction was documented 5 months following a normal pregnancy and delivery.
D N, Salem   +3 more
openaire   +2 more sources

GLC Analysis of Ergonovine Maleate

Journal of Pharmaceutical Sciences, 1974
A method is described for the quantitative determination of ergonovine maleate by GLC. Data are presented to show that this method provides the quantitative and semiquantitative results of the USP colorimetric assay and TLC in a single determination. Favorable quantitation is achieved by using brucine as internal standard.
openaire   +2 more sources

Ergonovine Testing in Patients with Exertional Angina

Acta Medica Scandinavica, 1987
ABSTRACT. Nordlander R, Orinius E (Division of Cardiology, Department of Internal Medicine, Thoracic Clinics, Karolinska Hospital, Stockholm, Sweden). Ergonovine testing in patients with exertional angina. Acta Med Scand 1987; 221:47–52.Injection of ergonovine has been suggested as a diagnostic test in patients with suspicion of a vasospastic ...
R, Nordlander, E, Orinius
openaire   +2 more sources

Menstrual Migraine and Intermittent Ergonovine Therapy

Headache: The Journal of Head and Face Pain, 1989
SYNOPSIS The treatment of patients suffering with menstrual migraine is sometimes a difficult and frustrating problem for the physician. As many menstrual migraine headaches are refractory to abortive therapy, prophylactic therapy is often needed.
openaire   +2 more sources

Prolonged coronary vasoconstrictor effect of ergonovine maleate

Catheterization and Cardiovascular Diagnosis, 1984
AbstractThe duration of the coronary artery vasoconstrictor effect of ergonovine maleate is an important clinical parameter that has not been clearly defined. Since ergonovine is generally administered in incremental, cumulative doses and since this agent may have potentially serious toxic effects related to its vasoconstrictor properties, knowledge of
Peter B. Kurnik   +5 more
openaire   +2 more sources

Effect of ergonovine maleate on puerperal prolactin

American Journal of Obstetrics and Gynecology, 1974
Abstract The effect of ergonovine maleate on prolactin levels in women on the third day post partum was studied because of ergonovine's known ability to lower circulating prolactin levels in animals and its apparent success in the treatment of nonpuerperal galactorrhea.
J M, Shane, F, Naftolin
openaire   +2 more sources

Ergonovine maleate test in various anginal syndromes

European Heart Journal, 1981
The ergonovine maleate (EM) test has been performed in four groups of 10 patients each: (A) variant angina; (B) angina at rest with ST segment depression during pain; (C) effort angina; (D) atypical chest i pain. EM was injected i.v. (highest dose 0-4 mg) first in the Coronary Care Unit and thereafter during coronary angiography.
A, Maresta   +5 more
openaire   +2 more sources

Ergonovine testing in a coronary care unit

The American Journal of Cardiology, 1980
This study describes the results of ergonovine testing in 100 consecutive patients who underwent this procedure in a coronary care unit. All patients had recently undergone coronary arteriography. A bolus injection of ergonovine was administered at 5 minute intervals in the following doses (mg): 0.0125, 0.025, 0.05, 0.1, 0.2, 0.3 and 0.4. The criterion
D D, Waters   +6 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy